1. Home
  2. Investing
  3. Stocks
  4. USA
  6. XBiotech Inc (XBIT)
  7. Quote


XBiotech Stock Price

0.08 (0.61%)
Upgrade to Real-Time
Afterhours (Closed)


52 Week Range


Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
Canadian Level 1 + USA
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
XBiotech Inc XBIT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.08 0.61% 13.21 16:25:01
Open Price Low Price High Price Close Price Prev Close
13.00 13.00 13.59 13.21 13.13
Bid Price Ask Price Spread News
13.00 16.50 3.50 1 -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
895 78,967 $ 13.26 $ 1,047,350 - 12.20 - 20.75
Last Trade Time Type Quantity Stock Price Currency
16:01:51 formt 438 $ 13.21 USD


Draw Mode:

XBiotech Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 401.30M 30.38M 15.29M $ 44.00M $ -30.97M -0.39 -31.50
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 07/15/21 50.00k 23.60%

more financials information »

XBiotech News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical XBIT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week12.6413.5912.4112.9869,7240.574.51%
1 Month15.5816.3012.2013.7588,320-2.37-15.21%
3 Months15.9516.6312.2014.7756,339-2.74-17.18%
6 Months17.0518.4612.2016.2474,577-3.84-22.52%
1 Year19.0420.7512.2017.3985,694-5.83-30.62%
3 Years3.2333.203.1715.35204,9689.98308.98%
5 Years13.2833.202.1312.65184,278-0.07-0.53%

XBiotech Description

XBiotech Inc is a US-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing MABp1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.